01st February 2022 | Pharma Updates

Infalliable Pharma Plans to Expand its Market

The company has started its operations as a distributor in the critical care segment.

Paolo Doncecchi joins Proteon Pharma as a Global Sales Director

He has more than 30 years of experience in marketing and sales at global biotech companies.

Alkem Labs partners with Johns Hopkins University

Alkem Laboratories has inked a licensing agreement with John Hopkins University for commercializing colorectal cancer treatment.

Japanese pharma company says Ivermectin effective against Omicron in phase 3 trial

The clinical trial found ivermectin has “an antiviral effect” against the Omicron infection, Kowa said without revealing more details.

GI Dynamics Secures Approval of the ISTEP Clinical Study in India

The company will study EndoBarrier® for glycemic improvement in patients with type 2 diabetes and obesity.

Roche bags USFDA approval for Vabysmo

Vabysmo is the fourth FDA-approved drug for “wet” age-related macular degeneration.

Glenmark gets nod for generic MetroGel

The drug is a generic version of Bausch Health US LLC’s MetroGel-Vaginal, which is used for the treatment of bacterial vaginosis.